To include your compound in the COVID-19 Resource Center, submit it here.

AltaRex falls on Phase IIb data

AltaRex (TSE:AXO) was off C$1.66 (67%)

Read the full 68 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE